• With MyRightDose, your patients can continue their Jaypirca therapy at the appropriate dose for them, without the hassle of delays or additional co-pays For more information, call 1-833-359-3286 Monday-Friday, 9 am-6 pm ET, or visit Jaypirca.com.
Jaypirca is a kinase inhibitor indicated for the treatment of adult patients with R/R MCL after at least two lines of systemic therapy, including a BT inhibitor. This indication is approved under accelerated approval based on response rate.